Coherus Oncology CHRS
NASDAQ CHRS
$0.75 +0.00 (+0.56%)
As of: Nov 6, 2026 · 9:54 AM EST

Coherus Oncology (CHRS) Shares Outstanding (Entity) (2013 - 2026)

Updated

Coherus Oncology (CHRS) posted Shares Outstanding (Entity) of 154.47 million for Q2 2026, up 32.9% from 116.22 million a year earlier and up 0.2% from the prior quarter.

Analysis

Coherus Oncology (CHRS) Shares Outstanding (Entity) (2013 - 2026) Analysis & Trends

For FY2025, Coherus Oncology's Shares Outstanding (Entity) came in at 121.15 million, up 4.8% from FY2024.

  • Annual Shares Outstanding (Entity) has increased for 13 consecutive years, with a five-year compound annual growth rate of 10.8% (FY2020 to FY2025).
  • In prior years, Coherus Oncology's Shares Outstanding (Entity) was 115.61 million in FY2024 (+3.0%), 112.22 million in FY2023 (+42.3%), 78.85 million in FY2022 (+2.5%) and 76.93 million in FY2021 (+6.1%).
  • The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Entity) in data going back to Q3 2013.
  • On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last 48 quarters, with growth averaging 10.4% over the last eight quarters.
  • The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.9% (Q3 2025) and 42.3% (Q4 2023) over the last five years.
  • According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 154.22 million (Q1 2026), 121.15 million (Q4 2025) and 116.24 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Eli Lilly 1,221.54 Bn 1,195.15 Bn 20.46 Bn 940.75 Mn
2 Johnson & Johnson 650.21 Bn 570.07 Bn 17.30 Bn 2.41 Bn
3 AbbVie 508.24 Bn 476.24 Bn 13.12 Bn 1.77 Bn
4 Merck 360.07 Bn 323.01 Bn 13.19 Bn 2.47 Bn
5 Novartis Ag 312.26 Bn 285.49 Bn - -
6 Astrazeneca 285.31 Bn 259.20 Bn 13.26 Bn -
7 Amgen 247.74 Bn 199.39 Bn 7.58 Bn 540.90 Mn
8 Gilead Sciences 207.12 Bn 182.22 Bn 6.73 Bn 1.24 Bn
9 Pfizer 166.13 Bn 113.48 Bn 12.56 Bn 5.70 Bn
10 Coherus Oncology 116.17 Mn -519.97 Mn 10.07 Mn 154.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 154.47 Mn
Mar 31, 2026 154.22 Mn
Dec 31, 2025 121.15 Mn
Sep 30, 2025 116.24 Mn
Jun 30, 2025 116.22 Mn
Mar 31, 2025 115.91 Mn
Dec 31, 2024 115.61 Mn
Sep 30, 2024 115.21 Mn
Jun 30, 2024 115.20 Mn
Mar 31, 2024 113.50 Mn
Dec 31, 2023 112.22 Mn
Sep 30, 2023 109.11 Mn
Jun 30, 2023 94.44 Mn
Mar 31, 2023 80.49 Mn
Dec 31, 2022 78.85 Mn
Sep 30, 2022 77.77 Mn
Jun 30, 2022 77.70 Mn
Mar 31, 2022 77.34 Mn
Dec 31, 2021 76.93 Mn
Sep 30, 2021 76.58 Mn
API Access

Coherus Oncology Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CHRS&period=max&api_key=YOUR_API_KEY